Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Hervé Watier »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hervé Pelloux < Hervé Watier < Hi Brunner  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000317 (2016) Jérémy Pottier [France] ; Romane Chastang [France] ; Christophe Dumet [France] ; Hervé Watier [France]Rethinking the INN system for therapeutic antibodies
000342 (2016) Franck Patin [France] ; Thomas Baranek [France] ; Patrick Vourc [France] ; Lydie Nadal-Desbarats [France] ; Jean-François Goossens [France] ; Sylviane Marouillat [France] ; Anne-Frédérique Dessein [France] ; Amandine Descat [France] ; Blandine Madji Hounoum [France] ; Clément Bruno [France] ; Hervé Watier [France] ; Mustafa Si-Tahar [France] ; Samuel Leman [France] ; Jean-Claude Lecron [France] ; Christian R. Andres [France] ; Philippe Corcia [France] ; Hélène Blasco [France]Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism
000385 (2015) David Ternant [France] ; Emilie Ducourau [France] ; Piéra Fuzibet [France] ; Céline Vignault [France] ; Hervé Watier [France] ; Thierry Lequerré [France] ; Xavier Le Loët [France] ; Olivier Vittecoq [France] ; Philippe Goupille [France] ; Denis Mulleman [France] ; Gilles Paintaud [France]Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Amyotrophic Lateral Sclerosis (drug therapy)
1Amyotrophic Lateral Sclerosis (genetics)
1Amyotrophic Lateral Sclerosis (metabolism)
1Animals
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Body Weight (genetics)
1Cytokines (blood)
1Disability Evaluation
1Disease Models, Animal
1Follow-Up Studies
1Gene Regulatory Networks
1Immunologic Factors (pharmacology)
1Immunologic Factors (therapeutic use)
1Interleukin-6 (genetics)
1Interleukin-6 (metabolism)
1Lipid Metabolism (drug effects)
1Locomotion (drug effects)
1Male
1Mice
1Mice, Inbred C57BL
1Mice, Transgenic
1Superoxide Dismutase (genetics)
1Superoxide Dismutase (metabolism)
1T-Lymphocytes, Regulatory (drug effects)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Hervé Watier" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Hervé Watier" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Hervé Watier
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021